Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non-bedridden patients, aged from 18 to 75 years, male or female; 2. Gastric adenocarcinoma confirmed by histopathology and/or cytology (including adenocarcinoma of gastroesophageal junction); 3. The subjects voluntarily joined the study, signed the informed consent form, had good compliance and cooperated with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Have suffered from other malignant tumors in the past 5 years, except for cured basal cell carcinoma of the skin and carcinoma in situ of the cervix; 2. Those who had received chemotherapy, radiotherapy or immunotherapy before participating in this study; 3) Any uncontrolled systemic diseases, including active infection, uncontrolled hypertension, diabetes, unstable angina pectoris, congestive heart failure, myocardial infarction (within 1 year before the start of treatment), severe arrhythmias requiring drug treatment, liver, kidney and metabolic diseases; 4. Accompanied by dysphagia, complete or incomplete digestive tract obstruction, active gastrointestinal bleeding, perforation; 5. Pregnant or lactating women; 6. Subjects who did not accept contraceptive requests during the study period; 7. Patients with a history of psychotropic substance abuse and unable to quit or with mental disorders; 8. Patients who are known to be allergic to possible chemotherapeutic drugs; 9. The researchers think that it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy rate; | — |
Countries
China
Contacts
The Seventh Affiliated Hospital of Sun Yat-Sen University